INTERVEST Exec On Challenges Limiting Korea’s Global Pharma Funds
Executive Summary
INTERVEST manages one of South Korea’s policy funds supporting the biopharma and healthcare industries. Executive managing director Junghee Lim sat down with Scrip to talk about challenges faced by venture capitals managing these funds, and why they may be a government program that Korea eventually abandons.
You may also be interested in...
More Govt Support For Pharma As Korea Plans New Fund
Following the successful launch of pharma development funds in the past few years, South Korea's health ministry is planning to create a new fund this year to further support domestic pharma firms' efforts to enter overseas markets and spur private sector investment in the broader healthcare industry.
AI Healthcare, Medical Devices Shine In Korea Q1 Financings
After the financing draught suffered by Korean bioventures in 2023, it now seems the VC market is poised for a recovery as investors shift attention again to the healthcare sector, with a spotlight on AI-based solutions and device firms.
Window Of Opportunity: Korea Unveils Cutting-Edge Bio Initiative
South Korea is moving forward with plan to set up a Boston-type biotech cluster in Osong as part of a broader initiative unveiled by President Yoon, while the biopharma industry is calling for rapid process, exceptional support.